Anja H. Pislar

Ljubljana, 1000, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction.

Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction.

Journal: Journal of medicinal chemistry

Published: May 06, 2026

Glial Cysteine Cathepsins: From Homeostasis to Neurodegeneration.

Glial Cysteine Cathepsins: From Homeostasis to Neurodegeneration.

Journal: Cellular and molecular neurobiology

Published: April 07, 2026

β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profiles.

β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profiles.

Journal: Biotechnology progress

Published: January 14, 2026

Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors.

Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 08, 2025

Neuronal Subtype-Specific Expression of γ-Enolase: Its Role in Neuronal Differentiation.

Neuronal Subtype-Specific Expression of γ-Enolase: Its Role in Neuronal Differentiation.

Journal: Neuromolecular medicine

Published: July 31, 2025

Transforming ureas into carbamates: From allosteric p38α MAPK ligands to dual BChE/p38α MAPK inhibitors.

Transforming ureas into carbamates: From allosteric p38α MAPK ligands to dual BChE/p38α MAPK inhibitors.

Journal: Bioorganic chemistry

Published: July 14, 2025

N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors.

N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors.

Journal: Chemico-biological interactions

Published: June 30, 2025

Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.

Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: June 02, 2025

Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease.

Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease.

Journal: Chemico-biological interactions

Published: May 23, 2025

Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer's disease.

Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer's disease.

Journal: Acta pharmaceutica Sinica. B

Published: December 02, 2024

New Inhibitors of β-1,4-Galactosyltransferase I Discovered by Virtual Screening.

New Inhibitors of β-1,4-Galactosyltransferase I Discovered by Virtual Screening.

Journal: ChemMedChem

Published: November 08, 2024

The α- to γ-enolase switch: The role and regulation of γ-enolase during oligodendrocyte differentiation.

The α- to γ-enolase switch: The role and regulation of γ-enolase during oligodendrocyte differentiation.

Journal: International journal of biological macromolecules

Published: October 22, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026